Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).

Desnos-Ollivier M, Bretagne S, Boullié A, Gautier C, Dromer F, Lortholary O; French Mycoses Study Group.

Clin Microbiol Infect. 2019 May;25(5):634.e1-634.e4. doi: 10.1016/j.cmi.2019.02.007. Epub 2019 Feb 14.

PMID:
30771532
2.

Corrigendum: Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997-2014 Longitudinal Study in Paris, France.

Guigue N, Léon L, Hamane S, Gits-Muselli M, Le Strat Y, Alanio A, Bretagne S.

Front Microbiol. 2018 Nov 27;9:2814. doi: 10.3389/fmicb.2018.02814. eCollection 2018.

3.

Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: A matched cohort study.

Dudoignon E, Alanio A, Anstey J, Depret F, Coutrot M, Fratani A, Jully M, Cupaciu A, Chaussard M, Oueslati H, Ferry A, Benyamina M, de Tymowski C, Boccara D, Serror K, Chaouat M, Mimoun M, Lafaurie M, Denis B, Gits-Muselli M, Bretagne S, Mebazaa A, Legrand M, Soussi S; PRONOBURN group.

Mycoses. 2019 Mar;62(3):237-246. doi: 10.1111/myc.12872. Epub 2018 Dec 18.

PMID:
30478963
4.

Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study.

Xhaard A, Porcher R, Bergeron A, Alanio A, Touratier S, Bretagne S, de Margerie-Mellon C, Sicre de Fontbrune F, Itzykson R, Coman T, Robin M, Cabannes-Hamy A, Socié G, Peffault de Latour R.

Ann Hematol. 2019 Apr;98(4):1033-1035. doi: 10.1007/s00277-018-3530-3. Epub 2018 Oct 23. No abstract available.

PMID:
30353389
5.

Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997-2014 Longitudinal Study in Paris, France.

Guigue N, Léon L, Hamane S, Gits-Muselli M, Le Strat Y, Alanio A, Bretagne S.

Front Microbiol. 2018 Oct 5;9:2369. doi: 10.3389/fmicb.2018.02369. eCollection 2018. Erratum in: Front Microbiol. 2018 Nov 27;9:2814.

6.

Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Robin C, Cordonnier C, Sitbon K, Raus N, Lortholary O, Maury S, Peffault de la Tour R, Bretagne S, Bastuji-Garin S; SAIF (Surveillance des Aspergilloses Invasives en France) and the SFGM-TC (Société Francophone de Greffe de Moelle et de Thérapie Cellulaire) Aspergillus Group.

Biol Blood Marrow Transplant. 2019 Feb;25(2):354-361. doi: 10.1016/j.bbmt.2018.09.028. Epub 2018 Sep 27.

PMID:
30268782
7.

Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis.

Pilmis B, Garcia-Hermoso D, Alanio A, Catherinot E, Scemla A, Jullien V, Bretagne S, Lortholary O.

Am J Transplant. 2018 Sep;18(9):2352-2355. doi: 10.1111/ajt.14940. Epub 2018 Jul 12.

PMID:
29790292
8.

Outbreak of Invasive Wound Mucormycosis in a Burn Unit Due to Multiple Strains of Mucor circinelloides f. circinelloides Resolved by Whole-Genome Sequencing.

Garcia-Hermoso D, Criscuolo A, Lee SC, Legrand M, Chaouat M, Denis B, Lafaurie M, Rouveau M, Soler C, Schaal JV, Mimoun M, Mebazaa A, Heitman J, Dromer F, Brisse S, Bretagne S, Alanio A.

MBio. 2018 Apr 24;9(2). pii: e00573-18. doi: 10.1128/mBio.00573-18.

9.

From phaeohyphomycosis to disseminated chromoblastomycosis: A retrospective study of infections caused by dematiaceous fungi.

Thomas E, Bertolotti A, Barreau A, Klisnick J, Tournebize P, Borgherini G, Zemali N, Jaubert J, Jouvion G, Bretagne S, Picot S.

Med Mal Infect. 2018 Jun;48(4):278-285. doi: 10.1016/j.medmal.2017.09.011. Epub 2018 Apr 12.

PMID:
29656841
10.

In Vitro and In Vivo Efficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, on Aspergillus fumigatus Infection.

Colley T, Sehra G, Chowdhary A, Alanio A, Kelly SL, Kizawa Y, Armstrong-James D, Fisher MC, Warrilow AGS, Parker JE, Kelly DE, Kimura G, Nishimoto Y, Sunose M, Onions S, Crepin D, Lagasse F, Crittall M, Shannon J, McConville M, King-Underwood J, Naylor A, Bretagne S, Murray J, Ito K, Strong P, Rapeport G.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e01941-17. doi: 10.1128/AAC.01941-17. Print 2018 May.

11.

Candiduria in kidney transplant recipients: Is antifungal therapy useful?

Denis B, Chopin D, Piron P, Resche-Rigon M, Bretagne S, Gits-Muselli M, Peraldi MN, Abboud I, Molina JM.

Mycoses. 2018 May;61(5):298-304. doi: 10.1111/myc.12740. Epub 2018 Feb 19.

PMID:
29280198
12.

Impact of alternative treatment approach for cerebral toxoplasmosis among HIV/AIDS patients from a resource-poor setting in Burkina Faso

Bamba S, Zoungrana J, Nikièma Z, Sondo AK, Ndiaye JL, Bretagne S.

Ann Parasitol. 2017;63(3):173–181. doi: 10.17420/ap6303.103.

13.

Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum.

Alanio A, Menotti J, Gits-Muselli M, Hamane S, Denis B, Rafoux E, Peffault de la Tour R, Touratier S, Bergeron A, Guigue N, Bretagne S.

Front Microbiol. 2017 Oct 31;8:2040. doi: 10.3389/fmicb.2017.02040. eCollection 2017.

14.

[Classical and molecular methods for identification and quantification of domestic moulds].

Fréalle E, Bex V, Reboux G, Roussel S, Bretagne S.

Rev Mal Respir. 2017 Dec;34(10):1124-1137. doi: 10.1016/j.rmr.2017.01.009. Epub 2017 Nov 15. Review. French.

PMID:
29153274
15.

Population Structure of Candida parapsilosis: No Genetic Difference Between French and Uruguayan Isolates Using Microsatellite Length Polymorphism.

Desnos-Ollivier M, Bórmida V, Poirier P, Nourrisson C, Pan D, Bretagne S, Puime A, Dromer F; French Mycoses Study Group; Uruguayan Invasive Fungal Infection Network.

Mycopathologia. 2018 Apr;183(2):381-390. doi: 10.1007/s11046-017-0224-7. Epub 2017 Nov 16.

PMID:
29147867
16.

A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations.

Menotti J, Alanio A, Sturny-Leclère A, Vitry S, Sauvage F, Barratt G, Bretagne S.

Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.

PMID:
28865757
17.

Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study.

Alanio A, Gits-Muselli M, Guigue N, Desnos-Ollivier M, Calderon EJ, Di Cave D, Dupont D, Hamprecht A, Hauser PM, Helweg-Larsen J, Kicia M, Lagrou K, Lengerova M, Matos O, Melchers WJG, Morio F, Nevez G, Totet A, White LP, Bretagne S.

EBioMedicine. 2017 Aug;22:155-163. doi: 10.1016/j.ebiom.2017.06.027. Epub 2017 Jun 29.

18.

Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us?

Alanio A, Bretagne S.

F1000Res. 2017 May 23;6:739. doi: 10.12688/f1000research.10619.1. eCollection 2017. Review.

19.

Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Alanio A, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S.

Clin Microbiol Rev. 2017 Jul;30(3):671-707. doi: 10.1128/CMR.00043-16. Review.

20.

Molecular Demonstration of a Pneumocystis Outbreak in Stem Cell Transplant Patients: Evidence for Transmission in the Daycare Center.

Robin C, Alanio A, Gits-Muselli M, la Martire G, Schlemmer F, Botterel F, Angebault C, Leclerc M, Beckerich F, Redjoul R, Pautas C, Toma A, Maury S, Bretagne S, Cordonnier C.

Front Microbiol. 2017 Apr 24;8:700. doi: 10.3389/fmicb.2017.00700. eCollection 2017.

21.

Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.

Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S; EVAMICA study team.

Intensive Care Med. 2017 Nov;43(11):1613-1625. doi: 10.1007/s00134-017-4766-4. Epub 2017 Apr 3.

22.

Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).

Bretagne S, Renaudat C, Desnos-Ollivier M, Sitbon K, Lortholary O, Dromer F; French Mycosis Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1784-1793. doi: 10.1093/jac/dkx045.

PMID:
28333259
23.

The risk and clinical outcome of candidemia depending on underlying malignancy.

Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F; French Mycoses Study Group.

Intensive Care Med. 2017 May;43(5):652-662. doi: 10.1007/s00134-017-4743-y. Epub 2017 Mar 20.

24.

Challenges in microbiological diagnosis of invasive Aspergillus infections.

Alanio A, Bretagne S.

F1000Res. 2017 Feb 17;6. pii: F1000 Faculty Rev-157. doi: 10.12688/f1000research.10216.1. eCollection 2017. Review.

25.

In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection.

Colley T, Alanio A, Kelly SL, Sehra G, Kizawa Y, Warrilow AGS, Parker JE, Kelly DE, Kimura G, Anderson-Dring L, Nakaoki T, Sunose M, Onions S, Crepin D, Lagasse F, Crittall M, Shannon J, Cooke M, Bretagne S, King-Underwood J, Murray J, Ito K, Strong P, Rapeport G.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02280-16. doi: 10.1128/AAC.02280-16. Print 2017 May.

26.

Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.

Ichai P, Laurent-Bellue A, Saliba F, Moreau D, Besch C, Francoz C, Valeyrie-Allanore L, Bretagne SR, Boudon M, Antonini TM, Artru F, Pittau G, Roux O, Azoulay D, Levesque E, Durand F, Guettier C, Samuel D.

Transplantation. 2017 Aug;101(8):1830-1837. doi: 10.1097/TP.0000000000001655.

PMID:
28207633
27.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.

Cordonnier C, Alanio A, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Bretagne S, Maertens J; Fifth European Conference on Infections in Leukemia (ECIL-5; a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN).

J Antimicrob Chemother. 2017 Apr 1;72(4):1266-1268. doi: 10.1093/jac/dkw580. No abstract available.

PMID:
28122911
28.

Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.

Dellière S, Healey K, Gits-Muselli M, Carrara B, Barbaro A, Guigue N, Lecefel C, Touratier S, Desnos-Ollivier M, Perlin DS, Bretagne S, Alanio A.

Front Microbiol. 2016 Dec 23;7:2038. doi: 10.3389/fmicb.2016.02038. eCollection 2016.

29.

Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diagnosis and Treatment.

Legrand M, Gits-Muselli M, Boutin L, Garcia-Hermoso D, Maurel V, Soussi S, Benyamina M, Ferry A, Chaussard M, Hamane S, Denis B, Touratier S, Guigue N, Fréalle E, Jeanne M, Shaal JV, Soler C, Mimoun M, Chaouat M, Lafaurie M, Mebazaa A, Bretagne S, Alanio A.

Clin Infect Dis. 2016 Nov 15;63(10):1312-1317. Epub 2016 Aug 17.

PMID:
27535951
30.

Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.

Gits-Muselli M, Benderdouche M, Hamane S, Mingui A, Feuilhade de Chauvin M, Guigue N, Picat MQ, Bourrat E, Petit A, Bagot M, Alanio A, Bretagne S.

Med Mycol. 2017 Jul 1;55(5):476-484. doi: 10.1093/mmy/myw107.

PMID:
27744309
31.

Copy Number Variation of Mitochondrial DNA Genes in Pneumocystis jirovecii According to the Fungal Load in BAL Specimens.

Valero C, Buitrago MJ, Gits-Muselli M, Benazra M, Sturny-Leclère A, Hamane S, Guigue N, Bretagne S, Alanio A.

Front Microbiol. 2016 Sep 12;7:1413. doi: 10.3389/fmicb.2016.01413. eCollection 2016.

32.

Performance evaluation of multiplex PCR including Aspergillus-not so simple!

Alanio A, Bretagne S.

Med Mycol. 2017 Jan 1;55(1):56-62. Epub 2016 Sep 23. Review.

PMID:
27664168
33.

ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Bretagne S, Cordonnier C; 5th European Conference on Infections in Leukaemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organisation for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN).

J Antimicrob Chemother. 2016 Sep;71(9):2397-404. doi: 10.1093/jac/dkw157. Epub 2016 May 12.

PMID:
27550992
34.

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

Alanio A, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Cordonnier C, Maertens J, Bretagne S; 5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN).

J Antimicrob Chemother. 2016 Sep;71(9):2386-96. doi: 10.1093/jac/dkw156. Epub 2016 May 12.

PMID:
27550991
35.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

Cordonnier C, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Bretagne S, Maertens J; Fifth European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN).

J Antimicrob Chemother. 2016 Sep;71(9):2379-85. doi: 10.1093/jac/dkw155. Epub 2016 May 12.

PMID:
27550990
36.

New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?

Alanio A, Denis B, Hamane S, Raffoux E, Peffault de la Tour R, Touratier S, Bergeron A, Bretagne S.

J Antimicrob Chemother. 2016 Aug;71(8):2075-8. doi: 10.1093/jac/dkw036. Review.

PMID:
27494830
37.

[Sinonasal fungal infections are not exclusively due to mucorales and Aspergillus!].

Tauziède-Espariat A, Wassef M, Adle-Biassette H, Alanio A, Bretagne S, Lanternier F, Boui M, Bouchaud O, Vironneau P, Kania R, Jouvion G, Chrétien F, Classe M.

Ann Pathol. 2016 Aug;36(4):245-51. doi: 10.1016/j.annpat.2016.04.005. Epub 2016 Jul 27. Review. French.

PMID:
27475007
38.

Variation in copy number of the 28S rDNA of Aspergillus fumigatus measured by droplet digital PCR and analog quantitative real-time PCR.

Alanio A, Sturny-Leclère A, Benabou M, Guigue N, Bretagne S.

J Microbiol Methods. 2016 Aug;127:160-163. doi: 10.1016/j.mimet.2016.06.015. Epub 2016 Jun 14.

PMID:
27316653
39.

Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing.

Alanio A, Gits-Muselli M, Mercier-Delarue S, Dromer F, Bretagne S.

Front Microbiol. 2016 May 24;7:733. doi: 10.3389/fmicb.2016.00733. eCollection 2016.

40.

Seroprevalence of Toxoplasma gondii and direct genotyping using minisequencing in free-range pigs in Burkina Faso.

Bamba S, Halos L, Tarnagda Z, Alanio A, Macé P, Moukoury S, Sangaré I, Guiguemdé R, Costa JM, Bretagne S.

Int J Food Microbiol. 2016 Aug 2;230:10-5. doi: 10.1016/j.ijfoodmicro.2016.04.016. Epub 2016 Apr 16.

PMID:
27111796
41.

[NEW STRATEGIES FOR THE MICROBIOLOGICAL DIAGNOSIS OF VISCERAL MYCOSES].

Alanio A, Bretagne S.

Rev Prat. 2015 Dec;65(10):1325-9. French.

PMID:
26979035
42.

(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.

Azoulay E, Guigue N, Darmon M, Mokart D, Lemiale V, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Bretagne S, Lebert C, Meert AP, Benoit D, Pene F.

Oncotarget. 2016 Apr 19;7(16):21484-95. doi: 10.18632/oncotarget.7471.

43.

Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model.

White PL, Wiederhold NP, Loeffler J, Najvar LK, Melchers W, Herrera M, Bretagne S, Wickes B, Kirkpatrick WR, Barnes RA, Donnelly JP, Patterson TF.

J Clin Microbiol. 2016 Apr;54(4):960-6. doi: 10.1128/JCM.03233-15. Epub 2016 Jan 20.

44.

Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?

Morton CO, White PL, Barnes RA, Klingspor L, Cuenca-Estrella M, Lagrou K, Bretagne S, Melchers W, Mengoli C, Caliendo AM, Cogliati M, Debets-Ossenkopp Y, Gorton R, Hagen F, Halliday C, Hamal P, Harvey-Wood K, Jaton K, Johnson G, Kidd S, Lengerova M, Lass-Florl C, Linton C, Millon L, Morrissey CO, Paholcsek M, Talento AF, Ruhnke M, Willinger B, Donnelly JP, Loeffler J; EAPCRI.

Med Mycol. 2017 Jun 1;55(4):402-413. doi: 10.1093/mmy/myw093.

PMID:
28339744
45.

Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).

Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V, Cassaing S, Chouaki T, Kauffmann-Lacroix C, Poirier P, Toubas D, Augereau O, Rocchi S, Garcia-Hermoso D, Bretagne S; French Mycosis Study Group.

Clin Microbiol Infect. 2016 Sep;22(9):810.e1-810.e8. doi: 10.1016/j.cmi.2015.12.006. Epub 2015 Dec 17.

46.

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.

Alanio A, Denis B, Hamane S, Raffoux E, Peffault de Latour R, Menotti J, Amorim S, Touratier S, Bergeron A, Bretagne S.

Emerg Infect Dis. 2016 Jan;22(1):157-8. doi: 10.3201/eid2201.150848. No abstract available.

47.

[Cryptococcus where they are not expected: Five case reports of extra-cerebral and extra-pulmonary cryptococcosis].

Cazorla A, Alanio A, Bretagne S, Polivka M, Shaar-Chneker C, Kaci R, Brouland JP, Chrétien F, Jouvion G.

Ann Pathol. 2015 Dec;35(6):479-85. doi: 10.1016/j.annpat.2015.10.001. Epub 2015 Nov 18. French.

PMID:
26596691
48.

Typing Candida Species Using Microsatellite Length Polymorphism and Multilocus Sequence Typing.

Garcia-Hermoso D, Desnos-Ollivier M, Bretagne S.

Methods Mol Biol. 2016;1356:199-214. doi: 10.1007/978-1-4939-3052-4_15.

PMID:
26519075
49.

High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?

Garcia-Hermoso D, Alanio A, Cabaret O, Olivi M, Foulet F, Cordonnier C, Costa JM, Bretagne S.

Mycoses. 2015 Sep;58(9):557-64. doi: 10.1111/myc.12356. Epub 2015 Jul 27.

PMID:
26214496
50.

Absence of Fungal Spore Internalization by Bronchial Epithelium in Mouse Models Evidenced by a New Bioimaging Approach and Transmission Electronic Microscopy.

Rammaert B, Jouvion G, de Chaumont F, Garcia-Hermoso D, Szczepaniak C, Renaudat C, Olivo-Marin JC, Chrétien F, Dromer F, Bretagne S.

Am J Pathol. 2015 Sep;185(9):2421-30. doi: 10.1016/j.ajpath.2015.04.027. Epub 2015 Jul 10.

PMID:
26165863

Supplemental Content

Loading ...
Support Center